Zobrazeno 1 - 10
of 1 764
pro vyhledávání: '"C. Veronesi"'
Publikováno v:
Il Foro Italiano, 2007 Oct 01. 130(10), 2785/2786-2801/2802.
Externí odkaz:
https://www.jstor.org/stable/23203080
Publikováno v:
Il Foro Italiano, 1984 Jun 01. 107(6), 301/302-303/304.
Externí odkaz:
https://www.jstor.org/stable/23176152
Autor:
Pardolesi, R.
Publikováno v:
Il Foro Italiano, 1985 Sep 01. 108(9), 2211/2212-2217/2218.
Externí odkaz:
https://www.jstor.org/stable/23177978
Publikováno v:
Il Foro Italiano, 1907 Jan 01. 32, 131/132-135/136.
Externí odkaz:
https://www.jstor.org/stable/23108814
Publikováno v:
Il Foro Italiano, 1933 Jan 01. 58, 1297/1298-1297/1298.
Externí odkaz:
https://www.jstor.org/stable/23134321
Publikováno v:
Il Foro Italiano, 1896 Jan 01. 21, 5/6-9/10.
Externí odkaz:
https://www.jstor.org/stable/23098089
Autor:
Luke R. Jackson, Megan R. Masi, Bryce M. Selman, George E. Sandusky, Hamideh Zarrinmayeh, Sudip K. Das, Surendra Maharjan, Nian Wang, Qi-Huang Zheng, Karen E. Pollok, Scott E. Snyder, Phillip Zhe Sun, Gary D. Hutchins, Elizabeth R. Butch, Michael C. Veronesi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Many drugs that show potential in animal models of glioblastoma (GBM) fail to translate to the clinic, contributing to a paucity of new therapeutic options. In addition, animal model development often includes histologic assessment, but multiparametr
Externí odkaz:
https://doaj.org/article/dce0b57be4ec432d8870dea6dcea66e1
Autor:
Jiao Wang, Yeonhee Yun, Karen E Pollok, Anthony L Sinn, Randy R Brutkiewicz, Michael C Veronesi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/523ab427e17a4043adc3ce5c1cd1b691
Autor:
Jiao Wang, Yeonhee Yun, Karen E Pollok, Anthony L Sinn, Randy R Brutkiewicz, Michael C Veronesi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5ebd8d0d7ec2472aa74b224b70099447
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Servier. Background/Introduction Several studies have shown that simplifying cardiovascular drug treatment by alleviating pill burden leads to better treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3b9a408eeca3745b6c9cb088ab4ea0f
https://doi.org/10.1093/eurjpc/zwad125.070
https://doi.org/10.1093/eurjpc/zwad125.070